Investigation of MGF mRNA expression in patients with amyotrophic lateral sclerosis using parallel in vivo and in vitro approaches

References

• Brown RH, Robberecht W. Amyotrophic lateral sclerosis: pathogenesis. Semin Neurol. 2001; 21: 131–9
   PubMed Web of Science ®Google Scholar
• Goodall EF, Morrison KE. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev Mol Med. 2006; 8: 1–22
   PubMedGoogle Scholar
• Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004; 185: 232–40
   PubMed Web of Science ®Google Scholar
• Echaniz-Laguna A, Zoll J, Ponsot E, N'guessan B, Tranchant C, Loeffler JP, et al. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol. 2006; 198: 25–30
   PubMed Web of Science ®Google Scholar
• Siciliano G, Pastorini E, Pasquali L, Manca ML, Iudice A, Murri L. Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci. 2001; 191: 61–5
   PubMed Web of Science ®Google Scholar
• Appel SH. Is ALS a systemic disorder? Evidence from muscle mitochondria. Exp Neurol. 2006; 198: 1–3
   PubMed Web of Science ®Google Scholar
• Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, et al. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol. 2005; 168: 193–9
   PubMed Web of Science ®Google Scholar
• Holzbaur EL, Howland DS, Weber N, Wallace K, She Y, Kwak S, et al. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis. 2006; 23: 697–707
   PubMed Web of Science ®Google Scholar
• Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol. 2003; 53: 804–7
   PubMed Web of Science ®Google Scholar
• Riddoch-Contreras J, Yang SY, Goldspink G, Orrell RW, Greensmith L. Mechano growth factor, an IGF-I splice variant, rescues motor neurons and improves muscle function in SOD1-G93A mice. Experimental Neurology. 2009; 215: 281–9
   PubMed Web of Science ®Google Scholar
• Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD, et al. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol. 2004; 555: 231–40
   PubMed Web of Science ®Google Scholar
• Yang S, Alnaqeeb M, Simpson H, Goldspink G. Cloning and characterization of an IGF-I isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil. 1996; 17: 487–95
   PubMed Web of Science ®Google Scholar
• Yang SY, Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Letters. 2002; 522: 156–60
   PubMed Web of Science ®Google Scholar
• Aperghis M, Johnson IP, Cannon J, Yang SY, Goldspink G. Different levels of neuroprotection by two insulin-like growth factor-I splice variants. Brain Res. 2004; 1009: 213–8
   PubMed Web of Science ®Google Scholar
• Barton ER. The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl Phyiol Nutr Metab. 2006; 31: 791–7
   PubMed Web of Science ®Google Scholar
• Mills P, Lafreniere JF, Benabdallah BF, El Fahime M, Tremblay JP. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor. Exp Cell Res. 2007; 313: 527–37
   PubMed Web of Science ®Google Scholar
• Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol. 2003; 547: 247–54
   PubMed Web of Science ®Google Scholar
• Kim JS, Cross JM, Bamman MM. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab. 2005; 288: E1110–9
   PubMed Web of Science ®Google Scholar
• Greig CA, Hameed M, Young A, Goldspink G, Noble B. Skeletal muscle IGF-I isoform expression in healthy women after isometric exercise. Growth Horm IGF Res. 2006; 16: 373–6
   PubMed Web of Science ®Google Scholar
• Cortes E, te Fong LF, Hameed M, Harridge S, Maclean A, Yang SY, et al. Insulin-like growth factor-I gene splice variants as markers of muscle damage in levator ani muscle after the first vaginal delivery. Am J Obstet Gynecol. 2005; 193: 64–70
   PubMed Web of Science ®Google Scholar
• Hameed M, Toft AD, Pedersen BK, Harridge SD, Goldspink G. Effects of eccentric cycling on IGF-I splice variant expression in the muscles of young and elderly people. Scand J Med Sci Sports. 2008; 18: 447–52
   PubMed Web of Science ®Google Scholar
• Ates K, Yang SY, Orrell RW, Sinanan AC, Simons P, Solomon A, et al. The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic and normal muscle. FEBS Lett. 2007; 581: 2727–32
   PubMed Web of Science ®Google Scholar
• Hill M, Goldspink G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol. 2003; 549: 409–18
   PubMed Web of Science ®Google Scholar
• Cheema U, Brown R, Mudera V, Yang SY, McGrouther G, Goldspink G. Mechanical signals and IGF-I gene splicing in vitro in relation to development of skeletal muscle. J Cell Physiol. 2005; 202: 67–75
   PubMed Web of Science ®Google Scholar
• Harridge SD, Kryger A, Stensgaard A. Knee extensor strength, activation, and size in very elderly people following strength training. Muscle Nerve. 1999; 22: 831–9
   PubMed Web of Science ®Google Scholar
• Cheema U, Yang SY, Mudera V, Goldspink G, Brown RA. 3-D in vitro model of early skeletal muscle development. Cell Motil Cytoskeleton. 2003; 54: 226–36
   PubMed Web of Science ®Google Scholar